Gout Disease Treatment Market Size, Share, Growth Report 2032

Gout Disease Treatment Market: Industry Perspective

The global gout disease treatment market size was worth around USD 2764.89 million in 2023 and is predicted to grow to around USD 5527.03 million by 2032 with a compound annual growth rate (CAGR) of roughly 8.00% between 2024 and 2032.

Request Free Sample

Global Gout Disease Treatment Market: Overview

Gout is a disease that is caused by frequent attacks of acute inflammatory arthritis. The symptoms of this disease include red and swollen joints, itching skin, limited movement of the affected part, and others. Also, the uric acid crystallizes and the crystals deposit in joints, tendons and adjacent tissues which causes a gout attack. The human body produces uric acid when it is broken down into purines. Purines are substances that are already present naturally in the body in the form of food consumed by humans. It is caused due to a combination of genetic factors and diet. Usually, the person consuming large amounts of meat and beer faces this disease.

Global Gout Disease Treatment Market: Growth Factors

The increase in the number of gout disease incidences and the strong development of the treatment are some of the major factors driving the global gout disease treatment market. Improvised studies on gout therapeutics and the introduction of niche drugs are other factors boosting the growth of the global gout disease treatment market. Progressive collaboration between major companies and quick product launches are some key factors impacting the growth of the market in a positive way. On the other hand, strict regulations and patent expiry of various drugs may act as key restraining factors for the global gout disease treatment market.

Request Free Sample

Global Gout Disease Treatment Market: Segmentation

The global gout disease treatment market is segmented on the basis of disease therapeutics and the conditional stage. The conditional stage segment is sub-segmented as acute gout and chronic gout. The therapeutic segment is further sub-segmented as urate-lowering therapies and inflammatory. The global market is segmented on the basis of the product as colchicine, non-steroidal anti-inflammatory drugs (NSAIDs), and corticosteroids. NSAIDs are widely used for the treatment of gout disease, while corticosteroids and colchicines are alternative treatments for patients who are unable to tolerate the effects of NSAIDs. Region-wise, the global market is segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Gout Disease Treatment Market: Report Scope

Global Gout Disease Treatment Market: Regional Analysis

North America and Europe dominate the global gout disease treatment market mainly owing to the enhanced pharmaceutical research in this area. North America is the leading player in the gout therapeutics market due to the increased geriatric population with modernized routine disorders. In addition, the U.S. holds the biggest market for gout Disease Treatment, followed by Canada in North America. Furthermore, Asia is anticipated to witness high growth shortly owing to increasing awareness among people about the disease. Japan, China, and India are expected to grow rapidly in the gout Disease Treatment market in Asia.

Gout Disease Treatment Market: Competitive Analysis

The global gout disease treatment market is dominated by players like:

• Novartis AG
• AstraZeneca PLC
• Polaris Group
• Teijin Pharma Limited
• BioCryst Pharmaceuticals, Inc.
• Nippon Chemiphar Co., Ltd.
• JW Pharmaceutical Corporation
• Addex Therapeutics
• Takeda Pharmaceutical Company
• LG Life Sciences Ltd.
• Pfizer
• Merck

By Conditional Stage Segment Analysis 

• Acute Gout 
• Chronic Gout

By Therapeutic Segment Analysis

• Urate-lowering therapies 
• Inflammatory

By Product Segment Analysis

• Colchicine
• Non-steroidal anti-inflammatory Drugs (NSAIDs)
• Corticosteroids

Gout Disease Treatment Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa